(Q53589878)

16 May 2018

title

Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice. (English)

1 reference

16 May 2018

0 references

1 reference

Na Xu

1

1 reference

16 May 2018

Lei Zhang

2

1 reference

16 May 2018

Jing Dong

3

1 reference

16 May 2018

Xian Zhang

4

1 reference

16 May 2018

Yan-Guang Chen

5

1 reference

16 May 2018

Bin Bao

6

1 reference

16 May 2018

Jian Liu

7

1 reference

16 May 2018

publication date

24 February 2014

1 reference

16 May 2018

Molecular Nutrition and Food Research

published in

1 reference

16 May 2018

volume

58

1 reference

16 May 2018

issue

6

1 reference

16 May 2018

page(s)

1258-1268

1 reference

16 May 2018

cites work

Angiogenesis and obesity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Distribution and biological activities of the flavonoid luteolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Regulation of glucose transport by insulin: traffic control of GLUT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Adipose tissue mass can be regulated through the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Cathepsin L activity controls adipogenesis and glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Deficiency of the cysteine protease cathepsin S impairs microvessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

The cellular and signaling networks linking the immune system and metabolism in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Macrophages, inflammation, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Mast cells in allergic and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Mast cells and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

The essential role of mast cells in orchestrating inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Mast cells and their mediators in cutaneous wound healing--active participants or innocent bystanders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

The complexity of the complicity of mast cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Advances in mast cell biology: new understanding of heterogeneity and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Mode of peroxisome proliferator-activated receptor γ activation by luteolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3K-Akt pathway and impairment of NF-κB translocation in LPS stimulated RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Opposite effects of quercetin, luteolin, and epigallocatechin gallate on insulin sensitivity under normal and inflammatory conditions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biologic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Mast cells and mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

Luteolin, a novel natural inhibitor of tumor progression locus 2 serine/threonine kinase, inhibits tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in JB6 mouse epidermis cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201300830

21 January 2018

Identifiers

DOI

10.1002/MNFR.201300830

1 reference

16 May 2018

release_ljeqxqjbqjf6xdrirrwiw4fyha

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ljeqxqjbqjf6xdrirrwiw4fyha

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 May 2018